Cytokinetics (NASDAQ:CYTK) Shares Gap Down on Analyst Downgrade
Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) gapped down before the market opened on Friday after UBS Group lowered their price target on the stock from $47.00 to $41.00. The stock had previously closed at $42.92, but opened at $37.68. UBS Group currently has a neutral rating on the stock. Cytokinetics shares last traded at […]
Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) gapped down before the market opened on Friday after UBS Group lowered their price target on the stock from $47.00 to $41.00. The stock had previously closed at $42.92, but opened at $37.68. UBS Group currently has a neutral rating on the stock. Cytokinetics shares last traded at […]
